Mayo Clinic researchers have found that an experimental drug, LCL161, stimulates the immune system, leading to tumor shrinkage in patients affected by multiple myeloma. The findings are published in Nature Medicine.
Mayo Clinic Laboratory and Pathology Research Roundup: May 8 - Insights
This week’s Research Roundup highlights how AKT-phosphorylated FOXO1 suppresses ERK activation and chemoresistance by disrupting IQGAP1-MAPK interaction.
Mayo Clinic Laboratory and Pathology Research Roundup: December 26 - Insights
This week's research roundup feature: Histoplasma and Blastomyces antigen detection assays are commonly used diagnostic tools. However, a high level of cross-reactivity between these antigens prevents definitive pathogen identification by...
Mayo Clinic Laboratory and Pathology Research Roundup: December 12 - Insights
This week's research roundup feature: Most patients with solitary bone plasmacytomas (SBP) progress to multiple myeloma (MM) after definitive radiation therapy as their primary treatment. Whether the presence of high-risk (HR) cytogenetic...
Mayo Clinic Laboratory and Pathology Research Roundup: January 16 - Insights
This week's research roundup feature: Understanding the incidence, causes, and trends of sudden cardiac death (SCD) among young competitive athletes is critical to inform preventive policies.
Perspectives Archives - Page 7 of 9 - Insights
Skip to Content MayoACCESS MayoLINK...
Evacuation of a Health Care Facility: When Disaster Strikes - Insights
Pat Hlavka, CSP, Safety Coordinator at Mayo Clinic, discusses the evacuation of a health care facility when disaster strikes.
Perspectives Archives - Page 8 of 9 - Insights
Skip to Content MayoACCESS MayoLINK...
Active Learning: Connecting Teachers and Learners - Insights
Cindy Gosse, Education Specialist in the Department of Laboratory Medicine and Pathology at Mayo Clinic, discusses how to use active learning to better connect teachers and learners.
Staffing to Workload in Phlebotomy Areas: Minimum Staffing Levels - Insights
Mike Baisch, Principal Systems Engineer at Mayo Clinic, discusses staffing to workload in phlebotomy areas with a focus on minimum-staffing levels, which can override the calculated staffing needs by adding staff to meet potential demands.